Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Gains from Investment Securities: 2020-2025

Historic Gains from Investment Securities for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to -$20,000.

  • Tango Therapeutics' Gains from Investment Securities fell 1100.00% to -$20,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $223,000, marking a year-over-year increase of 537.14%. This contributed to the annual value of $19.6 million for FY2024, which is 17.21% up from last year.
  • Per Tango Therapeutics' latest filing, its Gains from Investment Securities stood at -$20,000 for Q3 2025, which was down 108.00% from $250,000 recorded in Q2 2025.
  • Tango Therapeutics' Gains from Investment Securities' 5-year high stood at $23.8 million during Q1 2025, with a 5-year trough of -$83,000 in Q4 2021.
  • For the 3-year period, Tango Therapeutics' Gains from Investment Securities averaged around $5.6 million, with its median value being $2,000 (2024).
  • Per our database at Business Quant, Tango Therapeutics' Gains from Investment Securities surged by 31,615.26% in 2023 and then crashed by 1,100.00% in 2025.
  • Over the past 5 years, Tango Therapeutics' Gains from Investment Securities (Quarterly) stood at -$83,000 in 2021, then skyrocketed by 981.93% to $732,000 in 2022, then tumbled by 100.14% to -$1,000 in 2023, then plummeted by 800.00% to -$9,000 in 2024, then slumped by 1,100.00% to -$20,000 in 2025.
  • Its Gains from Investment Securities stands at -$20,000 for Q3 2025, versus $250,000 for Q2 2025 and $23.8 million for Q1 2025.